Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067377 · ClinicalTrials.gov registry record · NA
Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD
A NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02067377 is a NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia that has completed, run by Medical University of South Carolina. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02067377, a NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the use of a medical food, oral serum-derived bovine immunoglobulin/protein isolate (SBI), in helping patients with advanced COPD with cachexia (a wasting syndrome) improve their nutritional status and gain weight. The medical food is in powder form and is mixed with a liquid such as water or orange juice and consumed by swallowing. The primary hypothesis is that SBI protein isolate (SBI) will improve the nutritional status of cachexic patients with advanced stages of COPD.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Serum bovine immunoglobulin (SBI) medical food
- DIETARY_SUPPLEMENT Placebo (for serum bovine immunoglobulin)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02067377
The ClinicalTrials.gov registry entry for NCT02067377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced COPD (GOLD Stage 3 or 4) With Cachexia appearing as the primary indexed condition, and to 2 interventions - of which Serum bovine immunoglobulin (SBI) medical food is the first listed.
NCT02067377 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02067377 about?
NCT02067377 is a clinical study titled "Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD". This study will evaluate the use of a medical food, oral serum-derived bovine immunoglobulin/protein isolate (SBI), in helping patients with advanced COPD with cachexia (a wasting syndrome) improve their nutritional status and gain weight. The medical food is in powder form and is mixed with a liqui...
What is the current status of trial NCT02067377?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-12.
What conditions does trial NCT02067377 study?
This clinical trial studies the following conditions: Advanced COPD (GOLD Stage 3 or 4) With Cachexia.
What interventions are being tested in trial NCT02067377?
The interventions under investigation include: Serum bovine immunoglobulin (SBI) medical food (DIETARY_SUPPLEMENT), Placebo (for serum bovine immunoglobulin) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02067377?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02067377 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.